Review
Rev Diabet Stud,
2010,
7(2):112-123 |
DOI 10.1900/RDS.2010.7.112 |
The Quest for Tissue Stem Cells in the Pancreas and Other Organs, and their Application in Beta-Cell Replacement
Isabelle Houbracken, Luc Bouwens
Cell Differentiation Lab, Diabetes Research Center, Vrije Universiteit Brussel (Free University of Brussels), Laarbeeklaan 103, 1090 - Brussels, Belgium
Address correspondence to: Luc Bouwens, e-mail: lucbo@vub.ac.be
Manuscript submitted July 4, 2010; resubmitted July 7, 2010; accepted July 10, 2010.
Keywords: stem cell, duct, progenitor, beta-cell, acinar, transdifferentiation, lineage tracing, reprogramming
Abstract
Adult stem cell research has drawn a lot of attention by many researchers, due to its medical hope of cell replacement or regenerative therapy for diabetes patients. Despite the many research efforts to date, there is no consensus on the existence of stem cells in adult pancreas. Genetic lineage tracing experiments have put into serious doubt whether β-cell neogenesis from stem/progenitor cells takes place postnatally. Different in vitro experiments have suggested centroacinar, ductal, acinar, stellate, or yet unidentified clonigenic cells as candidate β-cell progenitors. As in the rest of the adult stem cell field, sound and promising observations have been made. However, these observations still need to be replicated. As an alternative to committed stem/progenitor cells in the pancreas, transdifferentiation or lineage reprogramming of exocrine acinar and endocrine α-cells may be used to generate new β-cells. At present, it is unclear which approach is most medically promising. This article highlights the progress being made in knowledge about tissue stem cells, their existence and availability for therapy in diabetes. Particular attention is given to the assessment of methods to verify the existence of tissue stem cells.
Fulltext:
HTML
, PDF
(576KB)
This article has been cited by other articles:
|
Concise review: clinical programs of stem cell therapies for liver and pancreas
Lanzoni G, Oikawa T, Wang Y, Cui CB, Carpino G, Cardinale V, Gerber D, Gabriel M, Dominguez-Bendala J, Furth ME, Gaudio E, Alvaro D, Inverardi L, Reid LM
Stem Cells 2013. 31(10):2047-2060
|
|
|
The use of stem cells for pancreatic regeneration in diabetes mellitus
Bouwens L, Houbracken I, Mfopou JK
Nat Rev Endocrinol 2013. 9(10):598-606
|
|
|
Research progress of stem cell therapy for type 1 diabetes mellitus
Hu MJ, Pan XH, Pang RQ, Cai XM
Chin J Tissue Engin Res 2012. 16(23):4349-4353
|
|
|
Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors
Hindriksen S, Bijlsma MF
Cancers (Basel) 2012. 4(4):989-1035
|
|
|
Identifying thyroid stem/progenitor cells: advances and limitations
Fierabracci A
J Endocrinol 2011. In press
|
|
|
Adult pancreatic alpha-cells: a new source of cells for beta-cell regeneration
Chung CH, Levine F
Rev Diabet Stud 2010. 7(2):124-131
|
|
|